Folate Augmentation of Treatment-Evaluation for Depression (FolATED): randomised trial and economic evaluation
Research output: Contribution to journal › Article › peer-review
Electronic versions
DOI
Abstract
Background
Folate deficiency is associated with depression. Despite the biological plausibility of a causal link, the evidence that adding folate enhances antidepressant treatment is weak.
Objectives
(1) Estimate the clinical effectiveness and cost-effectiveness of folic acid as adjunct to antidepressant medication (ADM). (2) Explore whether baseline folate and homocysteine predict response to treatment. (3) Investigate whether response to treatment depends on genetic polymorphisms related to folate metabolism.
Keywords
- Adult, Antidepressive Agents, Cost-Benefit Analysis, Depression, Female, Folic Acid, Humans, Male, Polymorphism, Genetic, Risk Factors, Treatment Outcome, Wales, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
| Original language | English |
|---|---|
| Pages (from-to) | 1-159 |
| Journal | Health Technology Assessment |
| Volume | 18 |
| Issue number | 48 |
| DOIs | |
| Publication status | Published - Jul 2014 |